CYTK

NASDAQStock

Cytokinetics, Incorporated

$59.95-3.65 (-5.74%)

52-Week Range

$29.84

$68.26

Key Stats

Market Cap

7.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.51

Volume

1.2M

Avg Volume

2.1M

Performance

-10.18%

-3.47%

+21.36%

YTD

-2.80%

+35.14%

+58.90%

+147.02%

Price Chart

ETF Exposure

CYTK is held by 140 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SCHB	Schwab U.S. Broad Market ETF	0.01%	71,933	$4.6M	$38.14B	0.03%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.01%	21,831	$1.4M	$12.10B	0.03%
VTI	Vanguard Total Stock Market ETF	0.01%	3,873,587	$244.8M	$2.10T	0.03%
IWV	iShares Russell 3000 ETF	0.01%	29,782	$1.9M	$17.58B	0.20%
VTHR	Vanguard Russell 3000 ETF	0.01%	9,701	$613K	$5.50B	0.06%
AVLC	Avantis U.S. Large Cap Equity ETF	0.01%	1,565	$100K	$1.03B	0.15%
AVSU	Avantis Responsible U.S. Equity ETF	0.01%	570	$37K	$412.5M	0.15%
STXV	Strive 1000 Value ETF	0.01%	106	$7K	$75.7M	0.18%
AVTM	Avantis Total Equity Markets ETF 1	0.01%	979	$63K	$694.1M	0.23%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	1,757	$111K	$1.46B	0.24%
VT	Vanguard Total World Stock ETF	0.01%	85,014	$5.4M	$80.60B	0.06%
AVUQ	Avantis U.S. Quality ETF	0.01%	173	$11K	$194.3M	0.15%
ITDG	iShares LifePath Target Date 2055 ETF	0.01%	63	$4K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.01%	41	$3K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.01%	31	$2K	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.01%	14	$893	$9.5M	0.12%
RWK	Invesco S&P MidCap 400 Revenue ETF	0.01%	767	$49K	$1.08B	0.39%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	45	$3K	$33.4M	0.34%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	75	$5K	$59.0M	0.11%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	2,686	$172K	$2.84B	0.19%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	31	$2K	$30.3M	0.32%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	64	$4K	$64.1M	0.11%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	21,589	$1.4M	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	21,589	$1.4M	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	21,589	$1.4M	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	21,589	$1.4M	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	21,589	$1.4M	$3.7M	0.70%
AFTY	Pacer CSOP FTSE China A50 ETF	0.00%	17,302	$968K	$4.3M	0.70%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	810	$52K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	2,340	$150K	$3.28B	0.20%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	5	$297	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	6	$366	$8.3M	0.31%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	16	$1K	$26.4M	0.50%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	55	$4K	$81.7M	0.11%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	463	$29K	$1.43B	0.09%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	236	$15K	$618.9M	0.12%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	264	$17K	$733.2M	0.20%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	10	$631	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	33	$2K	$81.5M	0.10%

PreviousPage 3 of 3

About CYTK ETF Exposure

Cytokinetics, Incorporated (CYTK) is held by 140 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.3B, CYTK is a widely held institutional stock. The stock currently trades at $59.95. Investors can gain exposure to CYTK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CYTK, sorted by portfolio weight.